Despite the decline in the number of people affected with leprosy worldwide, an estimated two lakh cases continue to be reported every year. India accounts for more than half of the world's leprosy cases being reported every year, said the World Health Organization (WHO).
"Leprosy-related discrimination, stigma and prejudice are the most powerful barriers to ending leprosy for good, especially given the disease is 100 per cent curable when detected early," said Poonam Khetrapal Singh, WHO Regional Director for Southeast Asia.
Leprosy
Leprosy, caused by Mycobacterium leprae, affects any organ like skin, eyes, mucosa, periphery nerves or any other organ. It can cause irreversible disfigurement of the extremities and nerve damage.
Advertisement
‘Leprosy is an infectious disease causing nerve damage and severe skin sores in arms, legs, and skin. However, the condition is treatable in the early stages.’
Tweet it Now
According to WHO, apart from India, a significant number of leprosy cases are detected in the Southeast Asia region, Brazil, sub-Saharan Africa and the Pacific.
"Though leprosy is often equated with serious deformity and disability, the percentage of patients having these symptoms is down to six per cent, demonstrating the disease is being diagnosed earlier than ever," Singh added.
![Psoriasis]( "Psoriasis")
Psoriasis is a recurrent and complex inflammatory skin disorder that can have tremendous physical and psychological impact on the sufferer
She further noted that core public health interventions such as active case-finding, improved treatment regimens and strengthened surveillance continue to drive down leprosy's incidence and spread, but the disease's bio-social components must be brought to the fore.
"As outlined in WHO's Global Leprosy Strategy 2016-2020, policies that promote inclusion and aim at ending leprosy-related discrimination, stigma and prejudice should be at the front and at the center of all leprosy programs, as powerful tools to achieve a leprosy-free world," she noted.
Source: IANS
Psoriasis
Psoriasis is a recurrent and complex inflammatory skin disorder that can have tremendous physical and psychological impact on the sufferer
Advertisement
She further noted that core public health interventions such as active case-finding, improved treatment regimens and strengthened surveillance continue to drive down leprosy's incidence and spread, but the disease's bio-social components must be brought to the fore.
"As outlined in WHO's Global Leprosy Strategy 2016-2020, policies that promote inclusion and aim at ending leprosy-related discrimination, stigma and prejudice should be at the front and at the center of all leprosy programs, as powerful tools to achieve a leprosy-free world," she noted.
Source: IANS
Chromoblastomycosis
Chromoblastomycosis, a chronic fungal skin disease, infects the skin and subcutaneous tissue through the opening of a traumatic injury. This dermatiaceous fungal infection responds slowly to fungal treatment.
Advertisement
 DermatomyostitisDermatomyostitis (DM) is an uncommon, inflammatory disease affecting the connective tissues. It is characterized by symptoms such as skin rashes and muscle weakness. | Advertisement
|
Advertisement
